EGA
Eagle Global Advisors’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.7M | Buy |
36,369
+14,870
| +69% | +$6.03M | 0.6% | 40 |
|
|
2025
Q1 | $10.7M | Sell |
21,499
-24
| -0.1% | -$11.9K | 0.44% | 51 |
|
|
2024
Q4 | $11.2M | Buy |
21,523
+26
| +0.1% | +$13.5K | 0.46% | 50 |
|
|
2024
Q3 | $13.3M | Sell |
21,497
-450
| -2% | -$278K | 0.66% | 36 |
|
|
2024
Q2 | $12.1M | Buy |
21,947
+92
| +0.4% | +$50.9K | 0.64% | 39 |
|
|
2024
Q1 | $12.7M | Buy |
21,855
+1,573
| +8% | +$914K | 0.72% | 40 |
|
|
2023
Q4 | $10.8M | Sell |
20,282
-2,492
| -11% | -$1.32M | 0.65% | 40 |
|
|
2023
Q3 | $11.5M | Sell |
22,774
-38
| -0.2% | -$19.2K | 0.75% | 34 |
|
|
2023
Q2 | $11.9M | Sell |
22,812
-795
| -3% | -$415K | 0.78% | 33 |
|
|
2023
Q1 | $13.6M | Sell |
23,607
-100
| -0.4% | -$57.6K | 0.92% | 31 |
|
|
2022
Q4 | $13.1M | Sell |
23,707
-10,948
| -32% | -$6.03M | 0.9% | 33 |
|
|
2022
Q3 | $17.6M | Buy |
34,655
+8,345
| +32% | +$4.23M | 1.32% | 20 |
|
|
2022
Q2 | $14.3M | Sell |
26,310
-257
| -1% | -$140K | 1.05% | 27 |
|
|
2022
Q1 | $15.7M | Buy |
26,567
+11,240
| +73% | +$6.64M | 0.97% | 29 |
|
|
2021
Q4 | $10.2M | Sell |
15,327
-207
| -1% | -$138K | 0.64% | 47 |
|
|
2021
Q3 | $8.88M | Buy |
15,534
+810
| +6% | +$463K | 0.59% | 52 |
|
|
2021
Q2 | $7.43M | Buy |
14,724
+88
| +0.6% | +$44.4K | 0.48% | 59 |
|
|
2021
Q1 | $6.68M | Buy |
+14,636
| New | +$6.68M | 0.49% | 55 |
|